Captopril attenuates pressor responses to norepinephrine and vasopressin through depletion of endogenous angiotensin II
- 21 April 1982
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 49 (6) , 1537-1539
- https://doi.org/10.1016/0002-9149(82)90381-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Implication of Endogenous Prostaglandin System in the Antihypertensive Effect of Captopril, SQ14225, in Low Renin Hypertension : IX Conference on the Pathogenesis of HypertensionJapanese Circulation Journal, 1980
- Does captopril lower blood pressure in anephric patients?BMJ, 1979
- SQ 14, 225 attenuates the vascular response to norepinephrine in the rat mesenteric arteriesLife Sciences, 1979
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979
- The renin system in high blood pressure, from disbelief to reality: Converting-enzyme blockade for analysis and treatmentProgress in Cardiovascular Diseases, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MANThe Lancet, 1977
- Hormone interactions in the isolated rabbit heart. Synthesis and coronary vasomotor effects of prostaglandins, angiotensin, and bradykinin.Circulation Research, 1975
- Angiotensin I converting enzyme.Circulation Research, 1975
- RELEASE OF A PROSTAGLANDIN E-LIKE SUBSTANCE FROM CANINE KIDNEY BY BRADYKININ - COMPARISON WITH ELEDOISINCirculation Research, 1971